Sex-Based Differences in Cardiometabolic Biomarkers

Circulation

Volumn 135, Issue 6, 2017, Pages 544-555

  Lew, Jeanney ^a   Sanghavi, Monika ^a   Ayers, Colby R ^a,b   McGuire, Darren K ^a   Omland, Torbjørn ^b   Atzler, Dorothee ^d   Gore, Maria O ^a   Neeland, Ian ^a   Berry, Jarett D ^a   Khera, Amit ^a   Rohatgi, Anand ^a   De Lemos, James A ^a,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

biomarkers; body composition; cardiovascular diseases; menopause; sex; women

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; 6 N,N' DIMETHYLARGININE; ADIPOCYTOKINE; ADIPONECTIN; ADVANCED GLYCATION END PRODUCT RECEPTOR; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL ADHESION MOLECULE; CYSTATIN C; D DIMER; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOARGININE; INTERLEUKIN 18; LEPTIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; N(G),N(G) DIMETHYLARGININE; OSTEOPROTEGERIN; PHOSPHOLIPASE A2; SOLUBLE ENDOTHELIAL CELL ADHESION MOLECULE; TRIACYLGLYCEROL; TROPONIN T; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MUSCLE INJURY; MYOCYTE INJURY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; STRESS; BLOOD; CARDIOVASCULAR DISEASE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ADULT; BIOMARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS;

EID: 85012085357     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.116.023005     Document Type: Article

References (47)

1. Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE, Wenger NK, American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular and Stroke Nursing, and Council on Quality of Care and Outcomes Research Acute myocardial infarction in women: A scientific statement from the American Heart Association. Circulation 2016 133 916 947. doi: 10.1161/CIR.0000000000000351.
2. Lansky AJ, Ng VG, Maehara A, Weisz G, Lerman A, Mintz GS, De Bruyne B, Farhat N, Niess G, Jankovic I, Lazar D, Xu K, Fahy M, Serruys PW, Stone GW, Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes. JACC. Cardiovasc Imaging 2012 5 3 suppl S62 S72. doi: 10.1016/j.jcmg.2012.02.003.
3. O'Meara E, Clayton T, McEntegart MB, McMurray JJ, Piña IL, Granger CB, Ostergren J, Michelson EL, Solomon SD, Pocock S, Yusuf S, Swedberg K, Pfeffer MA, CHARM Investigators Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 2007 115 3111 3120. doi: 10.1161/CIRCULATIONAHA.106.673442.
4. Selvin E, Erlinger TP, Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004 110 738 743. doi: 10.1161/01.CIR.0000137913.26087.F0.
5. Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, Forouzanfar MH, Naghavi M, Mensah GA, Ezzati M, Murray CJ, Worldwide epidemiology of atrial fibrillation: A Global Burden of Disease 2010 Study. Circulation 2014 129 837 847. doi: 10.1161/CIRCULATIONAHA.113.005119.
6. Avgil Tsadok M, Jackevicius CA, Rahme E, Humphries KH, Behlouli H, Pilote L, Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation. JAMA 2012 307 1952 1958. doi: 10.1001/jama.2012.3490.
7. Lerner DJ, Kannel WB, Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population. Am Heart J 1986 111 383 390
8. Berger JS, Elliott L, Gallup D, Roe M, Granger CB, Armstrong PW, Simes RJ, White HD, Van de Werf F, Topol EJ, Hochman JS, Newby LK, Harrington RA, Califf RM, Becker RC, Douglas PS, Sex differences in mortality following acute coronary syndromes. JAMA 2009 302 874 882. doi: 10.1001/jama.2009.1227.
9. Huxley R, Barzi F, Woodward M, Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-Analysis of 37 prospective cohort studies. BMJ 2006 332 73 78. doi: 10.1136/bmj.38678.389583.7C.
10. Huxley RR, Woodward M, Cigarette smoking as a risk factor for coronary heart disease in women compared with men: A systematic review and meta-Analysis of prospective cohort studies. Lancet 2011 378 1297 1305. doi: 10.1016/S0140-6736(11)60781-2.
11. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G, WISE Investigators Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006 47 3 suppl S21 S29. doi: 10.1016/j.jacc.2004.12.084.
12. Gijsberts CM, Gohar A, Ellenbroek GH, Hoefer IE, de Kleijn DP, Asselbergs FW, Nathoe HM, Agostoni P, Rittersma SZ, Pasterkamp G, Appelman Y, den Ruijter HM, Severity of stable coronary artery disease and its biomarkers differ between men and women undergoing angiography. Atherosclerosis 2015 241 234 240. doi: 10.1016/j.atherosclerosis.2015.02.002.
13. Wiviott SD, Cannon CP, Morrow DA, Murphy SA, Gibson CM, McCabe CH, Sabatine MS, Rifai N, Giugliano RP, DiBattiste PM, Demopoulos LA, Antman EM, Braunwald E, Differential expression of cardiac biomarkers by gender in patients with unstable angina/non-ST-elevation myocardial infarction: A TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy-Thrombolysis In Myocardial Infarction 18) substudy. Circulation 2004 109 580 586. doi: 10.1161/01.CIR.0000109491.66226.26.
14. Khera A, McGuire DK, Murphy SA, Stanek HG, Das SR, Vongpatanasin W, Wians FH Jr, Grundy SM, de Lemos JA, Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005 46 464 469. doi: 10.1016/j.jacc.2005.04.051.
15. Thorand B, Baumert J, Döring A, Herder C, Kolb H, Rathmann W, Giani G, Koenig W, KORA Group Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006 184 216 224. doi: 10.1016/j.atherosclerosis.2005.04.011.
16. Victor RG, Haley RW, Willett DL, Peshock RM, Vaeth PC, Leonard D, Basit M, Cooper RS, Iannacchione VG, Visscher WA, Staab JM, Hobbs HH, Dallas Heart Study Investigators The Dallas Heart Study: A population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health. Am J Cardiol 2004 93 1473 1480. doi: 10.1016/j.amjcard.2004.02.058.
17. Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA and Lemos JA, Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J Am Coll Cardiol 2004 44 1812 1818
18. Rohatgi A, Owens AW, Khera A, Ayers CR, Banks K, Das SR, Berry JD, McGuire DK, de Lemos JA, Differential associations between soluble cellular adhesion molecules and atherosclerosis in the Dallas Heart Study: A distinct role for soluble endothelial cell-selective adhesion molecule. Arterioscler Thromb Vasc Biol 2009 29 1684 1690. doi: 10.1161/ATVBAHA.109.190553.
19. Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F, Willett D, Victor RG, Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: The Dallas Heart Study. Hypertension 2005 46 124 129. doi: 10.1161/01.HYP.0000169972.96201.8e.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412 419
21. Tikuisis P, Meunier P, Jubenville CE, Human body surface area: measurement and prediction using three dimensional body scans. Eur J Appl Physiol 2001 85 264 271. doi: 10.1007/s004210100484.
22. Neeland IJ, Ayers CR, Rohatgi AK, Turer AT, Berry JD, Das SR, Vega GL, Khera A, McGuire DK, Grundy SM, de Lemos JA, Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity (Silver Spring) 2013 21 E439 E447. doi: 10.1002/oby.20135.
23. Abate N, Garg A, Coleman R, Grundy SM, Peshock RM, Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice. Am J Clin Nutr 1997 65 403 408
24. Khouri MG, Peshock RM, Ayers CR, de Lemos JA, Drazner MH, A 4-Tiered classification of left ventricular hypertrophy based on left ventricular geometry: The Dallas heart study. Circ Cardiovasc Imaging 2010 3 164 171. doi: 10.1161/CIRCIMAGING.109.883652.
25. Chang AY, Abdullah SM, Jain T, Stanek HG, Das SR, McGuire DK, Auchus RJ, de Lemos JA, Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study. J Am Coll Cardiol 2007 49 109 116. doi: 10.1016/j.jacc.2006.10.040.
26. Parikh RH, Seliger SL, de Lemos J, Nambi V, Christenson R, Ayers C, Sun W, Gottdiener JS, Kuller LH, Ballantyne C, deFilippi CR, Prognostic significance of high-sensitivity cardiac troponin T concentrations between the limit of blank and limit of detection in community-dwelling adults: A metaanalysis. Clin Chem 2015 61 1524 1531. doi: 10.1373/clinchem.2015.244160.
27. Rohatgi A, Khera A, Berry JD, Givens EG, Ayers CR, Wedin KE, Neeland IJ, Yuhanna IS, Rader DR, de Lemos JA, Shaul PW, HDL cholesterol efflux capacity and incident cardiovascular events. N Engl J Med 2014 371 2383 2393. doi: 10.1056/NEJMoa1409065.
28. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N, Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001 104 3052 3056
29. Wolk R, Berger P, Lennon RJ, Brilakis ES, Johnson BD, Somers VK, Plasma leptin and prognosis in patients with established coronary atherosclerosis. J Am Coll Cardiol 2004 44 1819 1824. doi: 10.1016/j.jacc.2004.07.050.
30. Hellström L, Wahrenberg H, Hruska K, Reynisdottir S, Arner P, Mechanisms behind gender differences in circulating leptin levels. J Intern Med 2000 247 457 462
31. de Castro MA, Baltar VT, Marchioni DM, Fisberg RM, Sex differences in serum leptin and its relation to markers of cardiometabolic risk in middle-Aged adults: evidence from a population-based study. Nutrition 2015 31 491 497. doi: 10.1016/j.nut.2014.09.007.
32. Folsom AR, Alonso A, George KM, Roetker NS, Tang W, Cushman M, Prospective study of plasma D-dimer and incident venous thromboembolism: The Atherosclerosis Risk in Communities (ARIC) Study. Thromb Res 2015 136 781 785. doi: 10.1016/j.thromres.2015.08.013.
33. Brilakis ES, Khera A, Saeed B, Banerjee S, McGuire DK, Murphy SA, de Lemos JA, Association of lipoprotein-Associated phospholipase A2 mass and activity with coronary and aortic atherosclerosis: findings from the Dallas Heart Study. Clin Chem 2008 54 1975 1981. doi: 10.1373/clinchem.2008.107359.
34. Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MM, Witteman JC, Lipoprotein-Associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: The Rotterdam Study. Circulation 2005 111 570 575. doi: 10.1161/01.CIR.0000154553.12214.CD.
35. White HD, Held C, Stewart R, Tarka E, Brown R, Davies RY, Budaj A, Harrington RA, Steg PG, Ardissino D, Armstrong PW, Avezum A, Aylward PE, Bryce A, Chen H, Chen MF, Corbalan R, Dalby AJ, Danchin N, De Winter RJ, Denchev S, Diaz R, Elisaf M, Flather MD, Goudev AR, Granger CB, Grinfeld L, Hochman JS, Husted S, Kim HS, Koenig W, Linhart A, Lonn E, Lopez-Sendon J, Manolis AJ, Mohler ER 3rd, Nicolau JC, Pais P, Parkhomenko A, Pedersen TR, Pella D, Ramos-Corrales MA, Ruda M, Sereg M, Siddique S, Sinnaeve P, Smith P, Sritara P, Swart HP, Sy RG, Teramoto T, Tse HF, Watson D, Weaver WD, Weiss R, Viigimaa M, Vinereanu D, Zhu J, Cannon CP, Wallentin L, Darapladib for preventing ischemic events in stable coronary heart disease. N Engl J Med 2014 370 1702 1711
36. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, Böhm BO, Ritz E, Wanner C, Homoarginine, cardiovascular risk, and mortality. Circulation 2010 122 967 975. doi: 10.1161/CIRCULATIONAHA.109.908988.
37. Atzler D, Appelbaum S, Cordts K, Ojeda FM, Wild PS, Münzel T, Blankenberg S, Böger RH, Blettner M, Beutel ME, Pfeiffer N, Zeller T, Lackner KJ, Schwedhelm E, Reference intervals of plasma homoarginine from the German Gutenberg Health Study. Clin Chem Lab Med 2016 54 1231 1237. doi: 10.1515/cclm-2015-0785.
38. Atzler D, Gore MO, Ayers CR, Choe CU, Böger RH, de Lemos JA, McGuire DK, Schwedhelm E, Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study. Arterioscler Thromb Vasc Biol 2014 34 2501 2507. doi: 10.1161/ATVBAHA.114.304398.
39. Omland T, de Lemos JA, Holmen OL, Dalen H, Benth JŠ Nygård S, Hveem K, Røsjø H, Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: The HUNT study. Clin Chem 2015 61 646 656. doi: 10.1373/clinchem.2014.234369.
40. Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, Khera A, McGuire DK, Vega GL, de Lemos JA, Turer AT, Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile. J Am Coll Cardiol 2013 62 752 760. doi: 10.1016/j.jacc.2013.03.038.
41. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, Hashim I, Berry JD, Das SR, Morrow DA, McGuire DK, Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010 304 2503 2512. doi: 10.1001/jama.2010.1768.
42. Patel PC, Ayers CR, Murphy SA, Peshock R, Khera A, de Lemos JA, Balko JA, Gupta S, Mammen PP, Drazner MH, Markham DW, Association of cystatin C with left ventricular structure and function: The Dallas Heart Study. Circ Heart Fail 2009 2 98 104. doi: 10.1161/CIRCHEARTFAILURE.108.807271.
43. Neeland IJ, Turer AT, Ayers CR, Berry JD, Rohatgi A, Das SR, Khera A, Vega GL, McGuire DK, Grundy SM, de Lemos JA, Body fat distribution and incident cardiovascular disease in obese adults. J Am Coll Cardiol 2015 65 2150 2151. doi: 10.1016/j.jacc.2015.01.061.
44. Sanghavi M, Gulati M, Sex differences in the pathophysiology, treatment, and outcomes in IHD. Curr Atheroscler Rep 2015 17 511. doi: 10.1007/s11883-015-0511-z.
45. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd., Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25-year population-based study. Arch Intern Med 1998 158 585 593
46. Heit JA, The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol 2008 28 370 372. doi: 10.1161/ATVBAHA.108.162545.
47. Maffei S, Del Ry S, Prontera C, Clerico A, Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women. Clin Sci (Lond) 2001 101 447 453